Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Arita Prima Indonesia Tbk (APII) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Arita Prima Indonesia Tbk
UBC Medical Indonesia Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Arita Prima Indonesia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Arita Prima Indonesia Tbk trades at Rp182 (market cap 200.09B, 17.2K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp152 (market cap 556.95B, 60.83M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.8× Arita Prima Indonesia Tbk's market cap, and UBC Medical Indonesia Tbk. is more actively traded (60.83M versus 17.2K). Which is the better fit depends on your goals.

APIILABS
Market Cap
200.09B556.95B
Volume
17.2K60.83M
Lot
172608.34K
Turnover
3.14M10.26B
Average Price
182.51168.64
Value
3.14M10.26B
Indicative Equilibrium Price
152
Indicative Equilibrium Volume
4.52K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

APII
View details
LABS
View details

About Arita Prima Indonesia Tbk

PT Arita Prima Indonesia Tbk (the Company) was established on October 5, 2000. Since its founding in 2000, the company initially marketed under the brand Arita valve products manufactured by Unimech Group, a multinational business group from Malaysia that specializes in construction services and valve manufacturers, as well as supporting products. The Company is the only company that was granted by the relevant manufacturers in the distribution and marketing in Indonesia, for valve products from leading manufacturers in the world with brands Arita from Malaysia, RK Marine from China, and KVC from Japan.

Read more on APII

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS